Cite

HARVARD Citation

    Sandborn, W. et al. (n.d.). Long‐Term Safety of Adalimumab in Clinical Trials in Adult Patients With Crohn's Disease or Ulcerative Colitis. American journal of gastroenterology. p. . [Online]. 
  
Back to record